Clinical Trial Update: Kesimpta Pregnancy and Infant Safety Study Using Real World Data

View source ↗

Summary

A Novartis-sponsored real-world data study is evaluating Kesimpta (ofatumumab) pregnancy and infant safety in people with multiple sclerosis, currently recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Kesimpta (ofatumumab)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Multiple Sclerosis | Status: RECRUITING